Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

A 360-degree overview of paediatric NAFLD: recent insights.

Nobili V, Svegliati-Baroni G, Alisi A, Miele L, Valenti L, Vajro P.

J Hepatol. 2013 Jun;58(6):1218-29. doi: 10.1016/j.jhep.2012.12.003. Epub 2012 Dec 10. Review.

2.

Paediatric nonalcoholic fatty liver disease.

Alisi A, Carpino G, Nobili V.

Curr Opin Gastroenterol. 2013 May;29(3):279-84. doi: 10.1097/MOG.0b013e32835ff95e. Review.

PMID:
23493072
3.

Nonalcoholic fatty liver disease in children.

Alisi A, Locatelli M, Nobili V.

Curr Opin Clin Nutr Metab Care. 2010 Jul;13(4):397-402. doi: 10.1097/MCO.0b013e32833aae84. Review.

PMID:
20531177
4.

Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach.

Alisi A, Feldstein AE, Villani A, Raponi M, Nobili V.

Nat Rev Gastroenterol Hepatol. 2012 Jan 17;9(3):152-61. doi: 10.1038/nrgastro.2011.273. Review.

PMID:
22249728
5.

Metabolic disturbances in non-alcoholic fatty liver disease.

Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.

Clin Sci (Lond). 2009 Apr;116(7):539-64. doi: 10.1042/CS20080253. Review.

PMID:
19243311
6.

Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research.

Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE.

J Pediatr Gastroenterol Nutr. 2006 Oct;43(4):413-27. Review.

PMID:
17033514
7.

[Non-alcoholic fatty liver disease--new view].

Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, MiezyƄska-Kurtycz J, Milkiewicz P.

Pol Merkur Lekarski. 2008 Jun;24(144):568-71. Review. Polish.

PMID:
18702346
8.

Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.

Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE.

Aliment Pharmacol Ther. 2008 Jul;28(1):13-24. doi: 10.1111/j.1365-2036.2008.03703.x. Epub 2008 Apr 4. Review.

9.

Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.

Preiss D, Sattar N.

Clin Sci (Lond). 2008 Sep;115(5):141-50. doi: 10.1042/CS20070402. Review.

PMID:
18662168
10.

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.

Musso G, Gambino R, Cassader M, Pagano G.

Ann Med. 2011 Dec;43(8):617-49. doi: 10.3109/07853890.2010.518623. Epub 2010 Nov 2.

PMID:
21039302
11.

Non-alcoholic steatohepatitis in children.

Nanda K.

Pediatr Transplant. 2004 Dec;8(6):613-8. Review.

PMID:
15598336
12.

[Pediatric non-alcoholic fatty liver disease: recent advances and challenges].

Poggiogalle E, Olivero G, Anania C, Ferraro F, Pacifico L.

Minerva Pediatr. 2010 Dec;62(6):569-84. Review. Italian.

PMID:
21042270
13.

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.

Vernon G, Baranova A, Younossi ZM.

Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30. Review.

14.

Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Younossi ZM.

Aliment Pharmacol Ther. 2008 Jul;28(1):2-12. doi: 10.1111/j.1365-2036.2008.03710.x. Epub 2008 Apr 11. Review.

15.

Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.

Moore JB.

Proc Nutr Soc. 2010 May;69(2):211-20. doi: 10.1017/S0029665110000030. Epub 2010 Feb 17. Review.

PMID:
20158939
16.

The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.

Miele L, Forgione A, Hernandez AP, Gabrieli ML, Vero V, Di Rocco P, Greco AV, Gasbarrini G, Gasbarrini A, Grieco A.

Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5):273-7. Review.

PMID:
16231589
17.

Non-alcoholic fatty liver disease and childhood obesity.

Mathur P, Das MK, Arora NK.

Indian J Pediatr. 2007 Apr;74(4):401-7. Review.

PMID:
17476088
18.

Review article: diagnosis and treatment of non-alcoholic fatty liver disease.

Oh MK, Winn J, Poordad F.

Aliment Pharmacol Ther. 2008 Sep 1;28(5):503-22. doi: 10.1111/j.1365-2036.2008.03752.x. Epub 2008 Jun 3. Review.

20.

Current and future therapeutic strategies in NAFLD.

Mark N, de Alwis W, Day CP.

Curr Pharm Des. 2010 Jun;16(17):1958-62. Review.

PMID:
20370671

Supplemental Content

Support Center